-
DSP Healthcare Fund Regular Growth
Equity healthcare
Overview ( as on 12/12/25 )
NAV
₹39.3
Last change
₹0.04 +0.0%
Fund Size (AUM)
3178.53 Cr
Performance
16.12% (5Y)
Fund Details
DSP Healthcare Fund Regular Growth
as of 12/12/25
AUM
3178.53 Cr
Expense Ratio
1.91 %
Benchmark
BSE Healthcare TR INR
ISIN
INF740KA1LD8
Fund Manager
Chirag Dagli
Exit Load
0.5% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| DSP Healthcare Fund Regular Growth | -4.79% | 20.92% | 16.12% |
| BSE Healthcare TR INR | 2.79% | 23.3% | 17.18% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
8.85% |
Cipla Ltd |
8.63% |
Ipca Laboratories Ltd |
7.76% |
Laurus Labs Ltd |
6.21% |
Cohance Lifesciences Ltd |
5.27% |
Gland Pharma Ltd |
5.1% |
Sai Life Sciences Ltd |
4.99% |
Apollo Hospitals Enterprise Ltd |
4.49% |
Alembic Pharmaceuticals Ltd |
4.08% |
Pfizer Ltd |
3.14% |
Sector Allocation
Healthcare |
98.47% |
Financial |
1.53% |
Technology |
0.0% |
Asset Allocation
-
98%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
18.43% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
17.76% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
15.82% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
15.82% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
15.82% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
17.31% (5Y)
-
